Adderall shortage persists while demand in US is higher than ever
The following is an excerpt from The Vaccine Reaction. On Oct. 12 the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), […]
Continue reading Adderall shortage persists while demand in US is higher than ever on sharylattkisson.com.
